Ianalumab, an investigational fully human monoclonal antibody drug being studied for its potential to treat various B cell-driven autoimmune diseases, received a Breakthrough Therapy designation for ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Alixorexton at all doses demonstrated significant improvements from baseline in mean sleep latency compared with placebo. The Food and Drug Administration (FDA) has granted Breakthrough Therapy ...

Please provide your email address to receive an email when new articles are posted on . If approved, privosegtor would become the first neuroprotective therapy for optic neuropathies. The PIONEER 1 ...

Oculis Holding (OCS) added ~11% on Tuesday after the Swiss drug developer announced the breakthrough therapy designation for its eye disease therapy Privosegtor as a treatment for optic neuritis (ON), ...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...

The Ceribell EEG headcap. [Image from the company] Ceribell (Nasdaq:CBLL) announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke detection ...

The Philadelphia Phillies have a left-handed pitching prospect that has been on a slow, but steady, rise in their farm system. Crawford was the Phillies’ first-round pick in 2022 out of Bishop Gorman ...

A UC San Diego lab recently announced a pair of scientific breakthroughs for Pitt-Hopkins and Rett syndromes that are slated for government-approved clinical trials soon. The approvals by the U.S.

(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company developing imaging and AI-enabled capsule endoscopy solutions, announced the submission of its 510(k) application to ...

CARDIOVASCULAR disease (CVD) remains a leading global cause of illness and death, with excess weight a major contributing risk factor. Dietary strategies such as intermittent fasting and calorie ...